We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-3.05%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$17.8B
AUM Growth
+$1.43B
Cap. Flow
+$2.47B
Cap. Flow %
13.89%
Top 10 Hldgs %
2.97%
Holding
5,084
New
749
Increased
1,923
Reduced
1,590
Closed
686

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$70.4M
2
CHTR icon
Charter Communications
CHTR
+$62M
3
COST icon
Costco
COST
+$48.5M
4
CME icon
CME Group
CME
+$44.7M
5
KO icon
Coca-Cola
KO
+$36.8M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$55.4M
2
NFLX icon
Netflix
NFLX
+$48.9M
3
ADM icon
Archer Daniels Midland
ADM
+$41.4M
4
WDAY icon
Workday
WDAY
+$40.1M
5
NXPI icon
NXP Semiconductors
NXPI
+$39.4M

Sector Composition

Rank Sector Weight
1 Financials 14.69%
2 Technology 13.52%
3 Healthcare 9.74%
4 Consumer Discretionary 8.75%
5 Industrials 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPTKU
3926
DELISTED
SportsTek Acquisition Corp. Unit
SPTKU
$132K ﹤0.01%
+13,449
New +$133K
NSTB.U
3927
DELISTED
Northern Star Investment Corp. II Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant
NSTB.U
$131K ﹤0.01%
13,255
+2,319
+21% +$22.8K
NMFC icon
3928
New Mountain Finance
NMFC
$733M
$130K ﹤0.01%
11,246
-8,364
-43% -$107K
AEVA
3929
Aeva Technologies
AEVA
$1.72B
$129K ﹤0.01%
+13,794
New +$218K
ANNX icon
3930
Annexon
ANNX
$867M
$129K ﹤0.01%
20,904
– –
BCAB icon
3931
BioAtla
BCAB
$5.74M
$129K ﹤0.01%
335
-308
-48% -$101K
DXCM icon
3932
CALL
DexCom
DXCM
$33.5B
$129K ﹤0.01%
1,600
-3,600
-69% -$305K
ACRS icon
3933
Aclaris Therapeutics
ACRS
$864M
$128K ﹤0.01%
8,109
-941
-10% -$14.8K
ARDX icon
3934
Ardelyx
ARDX
$997M
$128K ﹤0.01%
107,661
+98,772
+1,111% +$94K
DAKT icon
3935
Daktronics
DAKT
$1.02B
$128K ﹤0.01%
47,287
+26,866
+132% +$92.4K
EVER icon
3936
EverQuote
EVER
$884M
$128K ﹤0.01%
18,697
-13,679
-42% -$128K
UFI icon
3937
UNIFI
UFI
$133M
$128K ﹤0.01%
+13,432
New +$167K
SPKBU
3938
DELISTED
Silver Spike Acquisition Corp II Units
SPKBU
$128K ﹤0.01%
+12,900
New +$127K
HUGS.U
3939
DELISTED
USHG Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-third of one Warrant
HUGS.U
$128K ﹤0.01%
+12,933
New +$128K
BOOT icon
3940
Boot Barn
BOOT
$5.06B
$127K ﹤0.01%
2,164
-67,887
-97% -$4.55M
LAB icon
3941
Standard BioTools
LAB
$310M
$126K ﹤0.01%
114,764
-11,038
-9% -$16.7K
RNAC icon
3942
Cartesian Therapeutics
RNAC
$257M
$126K ﹤0.01%
2,561
+588
+30% +$32.3K
AVACU
3943
DELISTED
Avalon Acquisition Inc. Units
AVACU
$126K ﹤0.01%
12,521
-8,202
-40% -$82.6K
HLLY icon
3944
Holley
HLLY
$392M
$125K ﹤0.01%
30,888
-112,770
-78% -$843K
OTLY
3945
Oatly Group
OTLY
$410M
$125K ﹤0.01%
2,374
-8,270
-78% -$572K
OZON
3946
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
$125K ﹤0.01%
13,500
– –
OPRT icon
3947
Oportun Financial
OPRT
$351M
$124K ﹤0.01%
28,407
-21,808
-43% -$155K
SHO icon
3948
Sunstone Hotel Investors
SHO
$1.99B
$124K ﹤0.01%
13,202
-26,054
-66% -$282K
ZVRA icon
3949
Zevra Therapeutics
ZVRA
$675M
$123K ﹤0.01%
19,771
-10,168
-34% -$57.6K
KNTE
3950
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$123K ﹤0.01%
+10,315
New +$135K
156 157
158
159 160

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q3 2022 Portfolio in Review

As of Q3 2022, Cubist Systematic Strategies held 5,084 positions worth $17.8B, up 8.8% from $16.4B the previous quarter. Its ten largest holdings account for 3% of the portfolio.

Cubist Systematic Strategies deployed $2.47B of net new capital in Q3 2022, opening 749 new positions and adding to 1,923 existing holdings. Its largest new stake was Global Blockchain Acquisition Corp. Common Stock: 845,248 shares worth $8.34M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Bank of America, an estimated $55.4M trimmed.

  • Cubist Systematic Strategies's largest Q3 2022 buy was Global Blockchain Acquisition Corp. Common Stock: 845,248 shares worth $8.34M.
  • Cubist Systematic Strategies added most to Visa in Q3 2022, an estimated $70.4M increase.
  • Cubist Systematic Strategies's biggest Q3 2022 reduction was Bank of America, cutting an estimated $55.4M.
  • Cubist Systematic Strategies fully exited Bristol-Myers Squibb in Q3 2022, selling an estimated $24.2M.
  • Cubist Systematic Strategies's ten largest holdings make up 3% of its $17.8B portfolio in Q3 2022.
  • Cubist Systematic Strategies opened 749 new positions and closed 686 in Q3 2022.
  • Cubist Systematic Strategies's portfolio value rose 8.8% quarter-over-quarter to $17.8B.

Based on Cubist Systematic Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.